Accretion Pharmaceuticals IPO Reservation
The Accretion Pharmaceuticals IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 25,87,300 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
The Retail Individual Investor (RII) category has the highest allocation with 12,22,800 shares, representing 47.26% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 1,41,700 shares (5.48%), while Non-Institutional Investors (NIIs) receive 12,22,800 shares (47.26%).
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 141700 | 5.48 | 0 |
| Non-Institutional | 1222800 | 47.26 | 0 |
| Retail Investors | 1222800 | 47.26 | 0 |
| Total | 2587300 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Accretion Pharmaceuticals IPO?
The Retail Individual Investor (RII) quota in the Accretion Pharmaceuticals IPO comprises 12,22,800 equity shares, representing 47.26% of the total IPO issue.
What is the reservation for QIBs in the Accretion Pharmaceuticals IPO?
Qualified Institutional Buyers (QIBs) have been allocated 1,41,700 equity shares, representing 5.48% of the total IPO issue.
What is the reservation for HNI investors in the Accretion Pharmaceuticals IPO?
The Non-Institutional Investors (NII) category has been allotted 12,22,800 equity shares (47.26%). This category is further divided into: Big HNI (bNII): - shares (%) Small HNI (sNII): - shares (%).
What is the category-wise reservation in the Accretion Pharmaceuticals IPO?
The Accretion Pharmaceuticals IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 1,41,700 shares (5.48%). Non-Institutional Investors (NII): 12,22,800 shares (47.26%). Retail Individual Investors (RII): 12,22,800 shares (47.26%).
Is there a shareholder quota in the Accretion Pharmaceuticals IPO?
No. The Accretion Pharmaceuticals IPO does not include a shareholder reservation.